If approved, it would be the first major new drug treatment for Parkinson’s in half a century. Richard Mailman, a University ...
New research shows patients with Parkinson's disease were more willing to help others after taking their dopamine-boosting ...
New research shows that dopamine decreases impulsivity by 20% compared to placebo, as shown by participants' willingness to ...
Glovadalen, a novel D1 receptor positive allosteric modulator, is linked to improve OFF time in patients with Parkinson’s ...
A research team from the University of Cologne conducted one of the most comprehensive studies on dopamine and ...
Discover the impact of dopamine on the brain's reward circuit, from pleasure to addiction, and how to find balance.
In one of the largest studies of its kind, researchers found that increasing dopamine levels with L-DOPA made people slightly ...
Investors reacted positively to news that the company was using a $50 million private placement to help fund a Phase 3 study.
The 2025 AASM guidelines recommend iron supplementation as the first-line treatment for RLS when ferritin levels are below 75 ng/mL. Dopamine agonists like ropinirole can reduce RLS symptoms but carry ...
The Brighterside of News on MSN
Weight-loss drug Semaglutide reduces cocaine use, study finds
A drug most often prescribed for diabetes and obesity might soon be prescribed to curb one of the world’s hardest to quit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback